Sort
326,823 grants matching “clinical trial”
Flavivirus Infections: Pathogenesis and Prevention
$1,890,839Alan L Rothman · University Of Rhode Island · P01 · FY2019 · AI
Trans-America Consortium of the Health Care Systems Research Network for the Precision Medicine Initiative Cohort Program
$1,890,835Christine C Johnson · Henry Ford Health System · OT2 · FY2016 · OD
PumpKIN Preclinical Program
$1,890,790Janet Simons · University Of Maryland Baltimore · N01 · FY2011 · HL
24/7 closed-loop in older subjects with type 1 diabetes
$1,890,761Roman Hovorka · University Of Cambridge · DP3 · FY2016 · DK
Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment
$1,890,694Scott Michael Schuetze · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
The UCLA Center for In Vivo Imaging in Cancer Biology
$1,890,657Harvey R. Herschman · University Of California Los Angeles · P50 · FY2008 · CA
SOUTHEAST CANCER CONTROL COSORTIUM, INC
$1,890,474Southeast Cancer Control Consortium · U10 · FY2003 · CA
PREBIOTIC INULIN TO LIMIT ANTIMICROBIAL-RESISTANT INFECTIONS DURING CRITICAL ILLNESS: A PHASE II CLINICAL TRIAL
$1,890,421The Trustees Of Columbia University In The City Of New York · · FY2019 · Defense Health Agency
Sickle cell disease molecular pathogenesis and drug therapy
$1,890,416William Eaton · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Thoracic and Gastrointestinal Oncology Branch Medical Clinical Core
$1,890,317Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2017 · CA
YALE COMPREHENSIVE CANCER CENTER
$1,889,710Thomas James Lynch · Yale University · P30 · FY2010 · CA
YALE COMPREHENSIVE CANCER CENTER
$1,889,710Thomas James Lynch · Yale University · P30 · FY2009 · CA
YALE COMPREHENSIVE CANCER CENTER
$1,889,710Richard L Edelson · Yale University · P30 · FY2008 · CA
HIV VACCINE CLINICAL TRIALS UNIT
$1,889,684University Of Rochester · U01 · FY2000 · AI
Pharmacokinetics and Drug Metabolism
$1,889,528Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Translational Immunology research: a support for clinical immunological research
$1,889,188Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2021 · AR
PHACS - Data and Operations Center
$1,888,985George R Seage · Harvard School Of Public Health · U01 · FY2009 · HD
Pathogenic Mechanisms in Spondyloarthritis
$1,888,928Robert Colbert · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
PP2A Anchoring Disruptor Therapy in Heart Failure
$1,888,812Federico Cividini · Cardiac Rsk3 Inhibitors, Llc · R44 · FY2022 · HL
Development of (R,R)-dehydronorketamine for treatment resistant depression
$1,888,435Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
CD40L adjuvanted clade C DNA and MVA HIV vaccines
$1,888,340Rama Rao Amara · Emory University · U19 · FY2018 · AI
COORDINATING CENTER FOR THE NCI CERVICAL CANCER LAST MILE INITIATIVE SELF-SAMPLING FOR HPV TESTING TO IMPROVE CERVICAL CANCER PREVENTI
$1,888,290Ethan Dmitrovsky · Leidos Biomedical Research, Inc. · N01 · FY2022 · CA
UCLA SPORE IN PROSTATE CANCER
$1,888,201University Of California Los Angeles · P50 · FY2002 · CA
Optimization of CXCR1/2 antagonist SX-576 for the treatment of BPD and COPD
$1,887,898Dean Yoshimasa Maeda · Syntrix Biosystems, Inc. · R44 · FY2014 · HL
ACE: Translational Studies of Insistence on Sameness in Autism
$1,887,880Edwin H Cook · University Of Illinois At Chicago · P50 · FY2009 · HD